Published in Invest Ophthalmol Vis Sci on June 24, 2009
Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. PLoS One (2012) 1.01
Ginsenoside Rg3 inhibits CXCR4 expression and related migrations in a breast cancer cell line. Int J Clin Oncol (2011) 0.78
Epigenetic regulation of CXCR4 expression by the ocular microenvironment. Invest Ophthalmol Vis Sci (2013) 0.78
Orchestrating epigenetic roles targeting ocular tumors. Onco Targets Ther (2016) 0.77
The biology of uveal melanoma. Cancer Metastasis Rev (2017) 0.75
Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell (2007) 14.87
The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev (1989) 13.15
Cancer and the chemokine network. Nat Rev Cancer (2004) 10.27
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood (2005) 5.21
CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res (2004) 4.53
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood (2003) 4.19
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell (2004) 4.17
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A (2003) 3.72
Epidemiologic aspects of uveal melanoma. Surv Ophthalmol (1988) 2.85
Chemokines and cancer. Int J Cancer (2006) 2.75
Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res (2000) 2.61
Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res (2005) 2.59
The bicyclam AMD3100 story. Nat Rev Drug Discov (2003) 2.59
Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol (2001) 2.52
Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol (2005) 2.41
Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res (2005) 2.28
Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res (2002) 2.06
Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol (2006) 2.03
Prognosis and treatment of disseminated uveal melanoma. Cancer (1993) 1.98
De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci U S A (1989) 1.90
Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci (2007) 1.68
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer (1995) 1.65
Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis (2007) 1.63
Regional treatment options for patients with ocular melanoma metastatic to the liver. Ann Surg Oncol (2004) 1.55
Cancer stem cells and tumor metastasis: first steps into uncharted territory. Cell Stem Cell (2007) 1.48
Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol (2006) 1.46
Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Cancer Res (2003) 1.41
Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration. Tumour Biol (2007) 1.35
Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF). Am J Pathol (1998) 1.17
Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100. Mini Rev Med Chem (2005) 1.10
Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases. Mol Cancer Ther (2006) 1.07
Small molecule CXCR4 chemokine receptor antagonists: developing drug candidates. Curr Med Chem (2007) 1.06
Differential expression of chemokine receptors on uveal melanoma cells and their metastases. Invest Ophthalmol Vis Sci (2008) 0.92
Metastatic uveal melanoma: diffuse hepatic metastasis in a patient with concurrent normal serum liver enzyme levels and liver scan. Arch Ophthalmol (1985) 0.92
Murine models of liver metastasis. Invasion Metastasis (1995) 0.92
CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type. Cancer Immunol Immunother (2007) 0.91
CXCR-4 knockdown by small interfering RNA inhibits cell proliferation and invasion of oral squamous cell carcinoma cells. J Oral Pathol Med (2008) 0.90
The ocular melanoma story. LIII Edward Jackson Memorial Lecture: Part II. Am J Ophthalmol (1997) 0.88
Role of epidermal growth factor receptor in the metastasis of intraocular melanomas. Invest Ophthalmol Vis Sci (1998) 0.83
A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration. Cell Cycle (2009) 0.81
Planned combined I-125 plaque irradiation and indirect ophthalmoscope laser therapy for choroidal malignant melanoma. Ophthalmic Surg (1993) 0.81
Influence of hepatocyte growth factor/scatter factor on the metastatic phenotype of B16 melanoma cells. Tumour Biol (1998) 0.78
Paracrine growth response as a major determinant in liver-specific colonization by in vivo selected B16 murine melanoma cells. Invasion Metastasis (1993) 0.77
Can we target the chemokine network for cancer therapeutics? Curr Cancer Drug Targets (2006) 0.77
Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci (2007) 2.09
The pathophysiology of Acanthamoeba keratitis. Trends Parasitol (2006) 1.52
IFN-γ-independent intraocular tumor rejection is mediated by a macrophage-dependent process that leaves the eye intact. J Leukoc Biol (2012) 1.42
Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci (2005) 1.34
Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatology (Oxford) (2009) 1.26
Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings. Invest Ophthalmol Vis Sci (2010) 1.17
Activation of tumor-specific CD4(+) T lymphocytes by major histocompatibility complex class II tumor cell vaccines: a novel cell-based immunotherapy. Cancer Res (2004) 1.16
Pathogenic Acanthamoeba spp secrete a mannose-induced cytolytic protein that correlates with the ability to cause disease. Infect Immun (2003) 1.14
Ocular surface APCs are necessary for autoreactive T cell-mediated experimental autoimmune lacrimal keratoconjunctivitis. J Immunol (2011) 1.12
IL-17A-dependent CD4+CD25+ regulatory T cells promote immune privilege of corneal allografts. J Immunol (2011) 1.07
Desiccating stress induces CD4+ T-cell-mediated Sjögren's syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-γ. Am J Pathol (2011) 1.07
Gammadelta T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10. J Immunol (2006) 1.06
Cutting edge: atopy promotes Th2 responses to alloantigens and increases the incidence and tempo of corneal allograft rejection. J Immunol (2005) 1.05
CD4(+) T-cell-mediated mechanisms of corneal allograft rejection: role of Fas-induced apoptosis. Transplantation (2005) 1.04
NK cells promote Th-17 mediated corneal barrier disruption in dry eye. PLoS One (2012) 1.02
Fate of MHC-matched corneal allografts in Th1-deficient hosts. Invest Ophthalmol Vis Sci (2004) 1.01
CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye. Immunology (2003) 1.00
IL-17 promotes immune privilege of corneal allografts. J Immunol (2010) 1.00
Effects of mannose on Acanthamoeba castellanii proliferation and cytolytic ability to corneal epithelial cells. Invest Ophthalmol Vis Sci (2003) 0.99
Role of interferon-gamma in a mouse model of allergic conjunctivitis. Invest Ophthalmol Vis Sci (2005) 0.99
Influence of immune privilege on ocular tumor development. Ocul Immunol Inflamm (2010) 0.97
Allergic conjunctivitis exacerbates corneal allograft rejection by activating Th1 and th2 alloimmune responses. J Immunol (2010) 0.97
PD-L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro. Invest Ophthalmol Vis Sci (2008) 0.96
Expansion of B cells is necessary for the induction of T-cell tolerance elicited through the anterior chamber of the eye. Int Arch Allergy Immunol (2007) 0.96
Two different regulatory T cell populations that promote corneal allograft survival. Invest Ophthalmol Vis Sci (2010) 0.96
Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye. J Immunol (2003) 0.96
Failure of Acanthamoeba castellanii to produce intraocular infections. Invest Ophthalmol Vis Sci (2005) 0.96
In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation. Invest Ophthalmol Vis Sci (2008) 0.95
The Th1/Th2 paradigm in ocular allergy. Curr Opin Allergy Clin Immunol (2005) 0.94
Peripheral tolerance via the anterior chamber of the eye: role of B cells in MHC class I and II antigen presentation. J Immunol (2006) 0.94
Splenic B cells act as antigen presenting cells for the induction of anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci (2003) 0.94
Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium. Ocul Surf (2005) 0.92
Differential expression of chemokine receptors on uveal melanoma cells and their metastases. Invest Ophthalmol Vis Sci (2008) 0.92
Role of contact lens wear, bacterial flora, and mannose-induced pathogenic protease in the pathogenesis of amoebic keratitis. Infect Immun (2005) 0.91
Effect of alloantibodies on corneal allograft survival. Invest Ophthalmol Vis Sci (2002) 0.91
Spontaneous autoimmune dacryoadenitis in aged CD25KO mice. Am J Pathol (2010) 0.91
PD-L1 expression on human ocular cells and its possible role in regulating immune-mediated ocular inflammation. Invest Ophthalmol Vis Sci (2008) 0.91
Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca. PLoS One (2011) 0.91
CD4+ T-cell-dependent tumour rejection in an immune-privileged environment requires macrophages. Immunology (2007) 0.90
Adaptive immune responses to Acanthamoeba cysts. Exp Eye Res (2002) 0.90
CD8+ T cells circumvent immune privilege in the eye and mediate intraocular tumor rejection by a TNF-alpha-dependent mechanism. J Immunol (2007) 0.88
NKT cell exacerbation of liver metastases arising from melanomas transplanted into either the eyes or spleens of mice. Invest Ophthalmol Vis Sci (2011) 0.88
Evaluation of ocular surface inflammation in the presence of dry eye and allergic conjunctival disease. Ocul Surf (2005) 0.88
Autoantibodies contribute to the immunopathogenesis of experimental dry eye disease. Invest Ophthalmol Vis Sci (2012) 0.87
Effect of immunization with the mannose-induced Acanthamoeba protein and Acanthamoeba plasminogen activator in mitigating Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (2007) 0.87
Effect of an anti-CD54 (ICAM-1) monoclonal antibody (UV3) on the growth of human uveal melanoma cells transplanted heterotopically and orthotopically in SCID mice. Int J Cancer (2006) 0.87
Paradigm shifts in the role of CD4+ T cells in keratoplasty. Discov Med (2010) 0.87
New twists to an old story: novel concepts in the pathogenesis of allergic eye disease. Curr Eye Res (2013) 0.86
Imaging breast cancer cells and tissues using peptide-labeled fluorescent silica nanoparticles. J Nanosci Nanotechnol (2008) 0.86
Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-{gamma}-dependent manner. J Leukoc Biol (2006) 0.86
Abrogating TNF-α expression prevents bystander destruction of normal tissues during iNOS-mediated elimination of intraocular tumors. Cancer Res (2011) 0.86
Acanthamoeba-cytopathic protein induces apoptosis and proinflammatory cytokines in human corneal epithelial cells by cPLA2α activation. Invest Ophthalmol Vis Sci (2012) 0.85
Immune privilege of the eye and fetus: parallel universes? Transplantation (2005) 0.85
Immunogenicity and immune privilege of corneal allografts. Chem Immunol Allergy (2007) 0.85
Role of phospholipase A₂ (PLA₂) inhibitors in attenuating apoptosis of the corneal epithelial cells and mitigation of Acanthamoeba keratitis. Exp Eye Res (2013) 0.84
Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells. Invest Ophthalmol Vis Sci (2004) 0.84
Reduction of liver metastasis of intraocular melanoma by interferon-beta gene transfer. Invest Ophthalmol Vis Sci (2003) 0.84
NKT cells are necessary for maximal expression of allergic conjunctivitis. Int Immunol (2010) 0.84
The immunobiology of Acanthamoeba keratitis. Microbes Infect (2006) 0.83
Ocular surface restoration using non-surgical transplantation of tissue-cultured human amniotic epithelial cells. Am J Ophthalmol (2006) 0.83
Anti-tumor effects of the peptide TMTP1-GG-D(KLAKLAK)(2) on highly metastatic cancers. PLoS One (2012) 0.83
Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion. Exp Eye Res (2007) 0.83
Resistance and susceptibility of human uveal melanoma cells to TRAIL-induced apoptosis. Arch Ophthalmol (2005) 0.81
IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye. J Immunol (2011) 0.81
Advances on Non-CD4 + Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ Transplantation. Transplantation (2015) 0.80
Role of activated macrophages in Acanthamoeba keratitis. J Parasitol (2007) 0.79
Effects of intensive antihypertensive treatment on Chinese hypertensive patients older than 70 years. J Clin Hypertens (Greenwich) (2013) 0.79
The interaction of Acanthamoeba castellanii cysts with macrophages and neutrophils. J Parasitol (2003) 0.79
Epigenetic regulation of CXCR4 expression by the ocular microenvironment. Invest Ophthalmol Vis Sci (2013) 0.78
Intracorneal instillation of latex beads induces macrophage-dependent protection against Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (2006) 0.78
Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment. Exp Eye Res (2006) 0.78
Role of IFN-γ in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells. J Leukoc Biol (2011) 0.78
Regional immunity and immune privilege. Chem Immunol Allergy (2007) 0.78
Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD. J Control Release (2012) 0.78